|
JP2021001902A
|
|
Evaluation method of composition suppressing increase in blood urate level
|
|
WO2020218148A1
|
|
Lipid peroxide production inhibitor
|
|
JP2020147565A
|
|
Resting metabolism enhancer
|
|
WO2020091014A1
|
|
Heart rate decreasing agent
|
|
JP2019214550A
|
|
Quick-acting-improving agent for oral mucosa administration for runny nose or nasal congestion
|
|
JP2019156834A
|
|
Trait improver
|
|
CN110709086A
|
|
Agent for improving arterial blood oxygen saturation
|
|
JP2019094305A
|
|
Method for producing orotic acid-carnitine mixed powder or fumaric acid-carnitine mixed powder
|
|
JP2018115123A
|
|
Body odor remover and body odor removal method
|
|
JP2018095590A
|
|
Blood uric acid value increase inhibitor and screening method of blood uric acid value increase inhibiting substance
|
|
JP2018093742A
|
|
Compositions containing orotic acid potassium salt and production process thereof
|
|
JP2018043963A
|
|
Probiotic products including spores of Bacillus natto
|
|
JP2018035076A
|
|
Oral composition having retinal ganglion cell death inhibiting activity
|
|
JP2016153395A
|
|
Oroticacid-containing eye drops
|
